The global in-vitro fertilization market size valued USD 715.3 million in 2020 to USD 1,242.4 million by 2027 at a CAGR of 10.3% during the forecast period 2021-2027. In-vitro fertilization (IVF) is a process where eggs (ovum) from the ovary of a woman are taken and fertilized with sperm in laboratory method, and the embryo (fertilized egg) is sent back to the uterus of the woman. In vitro fertilization is one of the many possible ways to enhance the chance to infertile couple to get pregnancy. IVF usage is depended upon the reasons for infertility. IVF can be an option in case of endometriosis or fallopian tube blockage in the woman or in case of poor quality or low sperm count in man. There are many other treatments for this condition like surgery which can be tried prior to IVF. IVF does not work for the woman who does not have the ovulating capability or the men who unable to produce the proper count of healthy sperms. Increasing in the number of delayed pregnancy cases among the women, growing awareness regarding consequences of infertility, and availability of favourable reimbursement policies, increase technological advancements in IVF process such as capsule in vitro fertilization and embryoscope, growing medical tourism globally are expected to accelerate the demand for in-vitro fertilization market. Rise infertility disorders and gynaecological diseases, increased focus on the innovation of IVF technologies by the clinical research centres, are the factors which are boosting the growth of the global IVF market. However, huge requirements of budget and time to run IVF procedures, difficulty in maintaining the IVF procedure, a risk of multiple conceives by women, ethical issues regarding gender selection, lack of awareness about issues regarding infertility in under-developed countries are expected to hamper the global IVF market growth.